Ocugen Statistics
Total Valuation
Ocugen has a market cap or net worth of $264.34 million. The enterprise value is $232.43 million.
Important Dates
The last earnings date was Friday, November 8, 2024, before market open.
Earnings Date | Nov 8, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Ocugen has 291.32 million shares outstanding. The number of shares has increased by 11.56% in one year.
Current Share Class | 291.32M |
Shares Outstanding | 291.32M |
Shares Change (YoY) | +11.56% |
Shares Change (QoQ) | +8.03% |
Owned by Insiders (%) | 1.36% |
Owned by Institutions (%) | 27.43% |
Float | 287.37M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 50.66 |
Forward PS | n/a |
PB Ratio | 6.48 |
P/TBV Ratio | 6.51 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 49.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.17.
Current Ratio | 2.58 |
Quick Ratio | 2.46 |
Debt / Equity | 0.17 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -103.30% and return on invested capital (ROIC) is -58.38%.
Return on Equity (ROE) | -103.30% |
Return on Assets (ROA) | -47.98% |
Return on Capital (ROIC) | -58.38% |
Revenue Per Employee | $72,308 |
Profits Per Employee | -$786,831 |
Employee Count | 65 |
Asset Turnover | 0.07 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +134.47% in the last 52 weeks. The beta is 3.76, so Ocugen's price volatility has been higher than the market average.
Beta (5Y) | 3.76 |
52-Week Price Change | +134.47% |
50-Day Moving Average | 0.98 |
200-Day Moving Average | 1.30 |
Relative Strength Index (RSI) | 44.59 |
Average Volume (20 Days) | 4,251,873 |
Short Selling Information
The latest short interest is 50.65 million, so 17.38% of the outstanding shares have been sold short.
Short Interest | 50.65M |
Short Previous Month | 51.92M |
Short % of Shares Out | 17.38% |
Short % of Float | 17.62% |
Short Ratio (days to cover) | 16.43 |
Income Statement
In the last 12 months, Ocugen had revenue of $4.70 million and -$51.14 million in losses. Loss per share was -$0.20.
Revenue | 4.70M |
Gross Profit | -26.92M |
Operating Income | -52.44M |
Pretax Income | -50.86M |
Net Income | -51.14M |
EBITDA | -50.89M |
EBIT | -52.44M |
Loss Per Share | -$0.20 |
Full Income Statement Balance Sheet
The company has $38.70 million in cash and $6.78 million in debt, giving a net cash position of $31.91 million or $0.11 per share.
Cash & Cash Equivalents | 38.70M |
Total Debt | 6.78M |
Net Cash | 31.91M |
Net Cash Per Share | $0.11 |
Equity (Book Value) | 40.63M |
Book Value Per Share | 0.14 |
Working Capital | 24.91M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$43.08 million and capital expenditures -$6.09 million, giving a free cash flow of -$49.17 million.
Operating Cash Flow | -43.08M |
Capital Expenditures | -6.09M |
Free Cash Flow | -49.17M |
FCF Per Share | -$0.17 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,115.79% |
Pretax Margin | -1,088.17% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -664.95% |
Dividends & Yields
Ocugen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.56% |
Shareholder Yield | -11.56% |
Earnings Yield | -19.35% |
FCF Yield | -18.60% |
Analyst Forecast
The average price target for Ocugen is $5.67, which is 524.86% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.67 |
Price Target Difference | 524.86% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 87.51% |
EPS Growth Forecast (5Y) | -39.89% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Ocugen has an Altman Z-Score of -1.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.87 |
Piotroski F-Score | 2 |